This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Urinary Incontinence, Multiple Sclerosis or Neurogenic Bladder
and you are
over 18
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will evaluate the safety and efficacy of OnabotulinumtoxinA (BOTOX®) for the treatment of urinary incontinence due to NDO in non-catheterizing patients with MS.

Provided treatments

  • Biological: OnabotulinumtoxinA
  • Drug: Placebo (Normal Saline)
Tris trial is registered with FDA with number: NCT01600716. The sponsor of the trial is Allergan and it is looking for 144 volunteers for the current phase.
Official trial title: